Kuda Pembere A coalition of girls’ rights and health advocates has condemned the deletion of Clause 11 from the Medical Services Amendment Bill, arguing that the decision preserves outdated administrative hurdles that continue to obstruct women and girls from accessing legal abortion care. Following the deletion of Clause 11 from the Medical Services Amendment Bill,
Read More
Kuda Pembere The first batch of cancer treatment equipment acquired under the Sugar Tax programme is now in Zimbabwe, with two machines earmarked for Parirenyatwa and Mpilo hospitals, a top Government official said on Friday. These are low energycancer machines which are currently housed at the National Pharmaceutical Company of Zimbabwe (NatPharm) warehouse, pending completion
Read More
Michael Gwarisa More than one in three American adults lives with obesity, and scientists have long known it fuels chronic inflammation linked to diabetes, heart disease, and fatty liver. Now, an NIH-funded study has uncovered the biological chain reaction behind this process, opening the door to new treatments beyond weight loss. New research funded by
Read More
Michael Gwarisa More than 7,400 patients in Japan have contributed to a breakthrough study identifying a hidden genetic mismatch that significantly increases the risk of life-threatening immune complications after umbilical cord blood transplantation. The research, led by Associate Professor Takakazu Kawase of Fujita Health University and the Japanese Society for Transplantation and Cellular Therapy (JSTCT)
Read More
Kuda Pembere The Government of Zimbabwe has commissioned a Nucleic Acid Testing (NAT) machine at the National Blood Service Zimbabwe (NBSZ), a development expected to significantly reduce turnaround times and enhance the safety of blood transfusions. Speaking at the commissioning ceremony, Health and Child Care Minister Dr Douglass Mombeshora described the installation as not only
Read More
Watch: Zimbabwe Launches Lenacapavir: New HIV Prevention Injection With 99.9% Protection Michael Gwarisa In a major step forward for HIV prevention, Zimbabwe has officially launched the rollout of Lenacapavir, a long-acting injectable drug that provides new protection options for communities at high risk of HIV infection. Zimbabwe joins South Africa, Kenya, Zambia, and Eswatini among
Read More